- Home
- Nephrology
- Contents
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Grants Accelerated Approval to Atrasentan for IgA Nephropathy The FDA has granted accelerated approval to atrasentan for adults with primary IgA nephropathy at risk of rapid progression. The Phase III ALIGN trial demonstrated that atra

8693 Reached6 Comments1 Likes
Medical Article
Welcome to MedX – Your Source for the Latest Medical Breakthroughs! FDA Approves First Treatment for IgG4-Related Disease – Inebilizumab becomes the first and only FDA-approved therapy for this rare, multi-organ immune condition, cutting flares by 87% in Phase 3 trials. Atrasentan Offers New Hope for IgA Nephropathy – The FDA grants accelerated app

3332 Reached1 Comments1 Likes